الرئيسية/أخبار/TIF Supports Administration Of COVID-19 Vaccine Booster Dose To Patients With Haemoglobin Disorders أخبارTIF News (AR)Press Releases TIF Supports Administration Of COVID-19 Vaccine Booster Dose To Patients With Haemoglobin Disorders أقل من دقيقة 211020_ TIF Announcement_COVID-19 Vaccine Boosters الوسوم#news TIF News COVID-19 Pandemic COVID-19 Vaccinations Haemoglobin Disorders Thalassaemia Patients Healthcare Professionals AtRisk COVID-19 Vaccines Sickle cell Vulnerable أقل من دقيقة فيسبوك X لينكدإن مشاركة عبر البريد طباعة